Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.१५%
१,०९५.४५
+१.६४
+०.१५%
—१,०९३.८११,०९६.५२१,१००.२२१,०९३.२०——
SIXC
Communications
SIXC
Communications
SIXC
+०.३४%
६१०.८५
+२.०८
+०.३४%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.१०%
१,२४०.९७
-१३.८४
-१.१०%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.६५%
१,७४९.७४
-११.३७
-०.६५%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४५.३९——
SIXM
Financials
SIXM
Financials
SIXM
-०.०७%
६४२.१२
-०.४६
-०.०७%
—६४२.५८६४४.८७६४८.४८६४१.४०——
SIXR
Staples
SIXR
Staples
SIXR
-०.२२%
८४९.२२
-१.९१
-०.२२%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२२%
२१७.४९
-०.४९
-०.२२%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.६३%
३,२६४.४५
+५२.६२
+१.६३%
—३,२११.८३३,२२७.२१३,२६७.७६३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.४८%
९४४.४३
-४.५५
-०.४८%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.२४%
१,४७१.०५
-३.४७
-०.२४%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६९.१७——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.६४%
२,४०७.४०
+१५.२८
+०.६४%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
4502:TYO
Takeda Pharmaceutical Co Ltd
JP¥ ५,२३९.००
-०.५९%
(-३१.००) 1D
मे १, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4502...
Open
JP¥ ५,२६०
High
JP¥ ५,२६०
Low
JP¥ ५,१९१
Mkt. cap
८३.३६ खरब
Avg. vol.
४३.६९ लाख
Volume
२६.२९ लाख
Dividend
३.७८%
Quarterly dividend
JP¥ ४९
Ex dividend date
२०२५ सेप्टेम्बर २९
P/E ratio
७२.५०
52-wk high
JP¥ ६,०३३
52-wk low
JP¥ ४,०००
EPS
JP¥ ७२
Shares outstanding
७८.४५ करोड
No. of employees
४७ हजार
News stories
From sources across the web
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees४७.५ हजार
Founded१७८१ जुन १२
Headquarters-
Sector-
Websitetakeda.com
Last report
२०२६ जनवरी २९
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -JPY
Revenue / Estimate
११.९२ खरब/ (१२.०२ खरब est.)JPY
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
१०.५३ खरब
११.०७ खरब
११.१३ खरब
११.९२ खरब
Cost of goods sold
३.७३ खरब
३.८५ खरब
३.८० खरब
४.०१ खरब
Cost of revenue
३.७३ खरब
३.८५ खरब
३.८० खरब
४.०१ खरब
Research and development expenses
२.१६ खरब
१.४४ खरब
१.६१ खरब
१.७५ खरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.९६ खरब
२.५६ खरब
२.५४ खरब
२.८३ खरब
Operating expense
५.५७ खरब
५.३५ खरब
५.६३ खरब
६.६१ खरब
Total operating expenses
९.३० खरब
९.२० खरब
९.४३ खरब
१०.६२ खरब
Operating income
१.२३ खरब
१.८७ खरब
१.७० खरब
१.२९ खरब
Other non operating income
-२४.८६ अरब
-७७.९६ अरब
७७.९६ अरब
-२.९५ खरब
EBT including unusual items
-१.०७ खरब
१.५१ खरब
२८.१७ अरब
१.३४ खरब
EBT excluding unusual items
१.०० खरब
१.५३ खरब
१.२९ खरब
१.१४ खरब
Income tax expense
-४.२० अरब
२६.३५ अरब
३९.९० अरब
३०.१३ अरब
Effective tax rate
३.९२%
१७.४९%
१४१.६४%
२२.५१%
Other operating expenses
-९१.२६ अरब
६.०३ अरब
१६.१२ अरब
६७.१३ अरब
Net income
-१.०३ खरब
१.२४ खरब
-११.८० अरब
१.०४ खरब
Net profit margin
-९.७९%
११.२३%
-१.०६%
८.७०%
Earnings per share
-
-
-
-
Interest and investment income
९.८५ अरब
७३.७६ अरब
४३.९२ अरब
२.७९ खरब
Interest expense
-७.८२ अरब
-२९.२० अरब
-१.६१ खरब
-
Net interest expenses
२.०३ अरब
४४.५६ अरब
-१.१७ खरब
२.७९ खरब
Depreciation and amortization charges
-
-
-
-
EBITDA
२.२२ खरब
३.६९ खरब
३.५५ खरब
१.८३ खरब
Gain or loss from assets sale
-२.३९ अरब
-१७.३२ अरब
३०.३० करोड
३५.८० करोड
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer